Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-27 @ 9:39 PM
Study NCT ID:
NCT00167661
Status:
TERMINATED
Last Update Posted:
2020-09-21
First Post:
2005-09-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
Sponsor:
University of Wisconsin, Madison
Organization:
Study Overview
Official Title:
Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
Status:
TERMINATED
Status Verified Date:
2020-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Enrollment suspended pending protocol revision to change study to observational
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: